The systemic antitumour effect of the triple therapy disappeared only when CD4+, CD8+ T cells and NK cells were knocked out, and the distant tumour grew rapidly and even tended to surpass that in the control group (Fig. 5d). The gene discussed is CD4; the disease is neoplasm.